Levine, D. A., Dizon, D. S., Carlson, J. W., Filiaci, V. L., Powell, M. A., Secord, A. A., … Aghajanian, C. A. (2018). Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P. In Gynecologic Oncology (Vol. 149, pp. 12–13). Elsevier BV. https://doi.org/10.1016/j.ygyno.2018.04.034

Levine, D. A., D. S. Dizon, J. W. Carlson, V. L. Filiaci, M. A. Powell, A. A. Secord, K. S. Tewari, et al. “Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P.” In Gynecologic Oncology, 149:12–13. Elsevier BV, 2018. https://doi.org/10.1016/j.ygyno.2018.04.034.

Levine DA, Dizon DS, Carlson JW, Filiaci VL, Powell MA, Secord AA, et al. Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P. In: Gynecologic Oncology. Elsevier BV; 2018. p. 12–3.

Levine, D. A., et al. “Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P.” Gynecologic Oncology, vol. 149, Elsevier BV, 2018, pp. 12–13. Crossref, doi:10.1016/j.ygyno.2018.04.034.

Levine DA, Dizon DS, Carlson JW, Filiaci VL, Powell MA, Secord AA, Tewari KS, Bender DP, O’Malley DM, Stuckey AR, Moore KN, Dewdney SB, Gao J, Dao F, Soslow RA, Lankes HA, Aghajanian CA. Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P. Gynecologic Oncology. Elsevier BV; 2018. p. 12–13.